Safety/Efficacy Study to Assess Whether FVIII/VWF Concentrate Can Induce Immune Tolerance in Haemophilia A Patients
Sintesi Research Srl
Centro Emofilia e Trombosi Angela Bianchi Bonomi, IRCCS Fondazione Ospedale Maggiore Policlinico

      The purpose of this study is to assess the role of a FVIII/VWF complex concentrate (Emoclot)
      in successfully inducing immune tolerance (I.T.I.) in patients with Haemophilia A with
      inhibitors, including patients at high risk of failure.
    
Drug